Loading
ペプチドリーム(株) is a listed company. Filings by its managers are published through EDINET (Japan FSA). 1 insider has disclosed 2 filings since 18 October 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
No insider has bought ペプチドリーム(株) shares on the open market in the past twelve months.
Compared with its exchange (3,423 companies, median 3 filings), a count of 2 filings is below the norm.
These figures are compiled from regulatory filings published by EDINET (Japan FSA). They describe what insiders did and are not a recommendation.
· cache
3 of 3 declarations
Peptidream is a Japanese company focused on the discovery and development of therapeutic peptides. It is listed on the XTKS market.